Introduction to AS-OCT in Ophthalmology

Modern ophthalmology relies heavily on precision imaging to distinguish between harmless growths and aggressive malignancies. Consequently, AS-OCT ocular surface lesions imaging has emerged as a cornerstone of non-invasive diagnostics. This technology provides high-resolution, cross-sectional views of the conjunctiva and cornea. Moreover, it allows clinicians to visualize tissue architecture that remains invisible during a standard slit-lamp examination. By providing an \"optical biopsy,\" AS-OCT helps doctors make faster, more accurate decisions for their patients.

Diagnostic Utility of AS-OCT Ocular Surface Lesions

Clinicians use AS-OCT to characterize a wide variety of entities. Firstly, it excels at identifying Ocular Surface Squamous Neoplasia (OSSN) by revealing a thickened, hyperreflective epithelium. In contrast, benign lesions like pterygia typically show a thin epithelium with subepithelial involvement. Furthermore, the modality is essential for assessing conjunctival melanoma, lymphoma, and amyloidosis. Because the procedure is non-contact, it ensures patient comfort while delivering objective data. Therefore, integrating this tool into routine practice significantly reduces the need for unnecessary invasive biopsies.

Clinical Impact and Therapy Monitoring

Beyond initial diagnosis, AS-OCT plays a vital role in long-term management. For instance, doctors use these scans to monitor the response to topical chemotherapy in OSSN cases. If a lesion persists subclinically, the imaging will detect it long before it becomes visible to the naked eye. Additionally, AS-OCT guides surgical margins, ensuring that surgeons remove all neoplastic tissue. Ultimately, this approach improves patient outcomes by minimizing recurrence and preserving ocular surface integrity. Clearly, the role of high-resolution imaging will only continue to grow in ophthalmic oncology.

Frequently Asked Questions

How does AS-OCT differ from a traditional biopsy?

AS-OCT provides a non-invasive \"optical biopsy\" that visualizes tissue layers without surgery. However, traditional histopathology remains the gold standard for definitive cellular diagnosis when imaging results are inconclusive.

Can AS-OCT distinguish between OSSN and pterygium?

Yes, AS-OCT is highly effective at this. OSSN typically presents with a thickened, hyperreflective epithelium, while pterygium shows normal epithelial thickness with underlying stromal changes.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Li WJ et al. Imaging of Ocular Surface Lesions Using Anterior Segment Optical Coherence Tomography. Clin Exp Ophthalmol. 2026 Feb 18. doi: 10.1111/ceo.70081. PMID: 41705454.


2. Kanavi MR et al. Anterior segment optical coherence tomography in conjunctival ocular surface disorders – A review. PMC (2025).


3. American Academy of Ophthalmology. AS-OCT in Ocular Surface Lesions. Clinical Education Video (2020).